Basit öğe kaydını göster

dc.contributor.authorGunaydin S.
dc.contributor.authorAyrancioglu K.
dc.contributor.authorDikmen E.
dc.contributor.authorMccusker K.
dc.contributor.authorVijay V.
dc.contributor.authorSari T.
dc.contributor.authorTezcaner T.
dc.date.accessioned2020-06-25T15:13:47Z
dc.date.available2020-06-25T15:13:47Z
dc.date.issued2007
dc.identifier.issn02676591
dc.identifier.urihttps://doi.org/10.1177/0267659107084146
dc.identifier.urihttps://hdl.handle.net/20.500.12587/1931
dc.descriptionPubMed: 18181517en_US
dc.description.abstractObjective. A manifestation of inflammatory injury to the heart, atrial fibrillation (AF), ranks among the most frequent and potentially life-threatening post-operative complications. Methods. In a prospective randomized study, 120 patients undergoing CABG were allocated into two groups (N = 60): Group 1- Polymethoxyethylacry late-coated circuits + Leukocyte filters (Terumo,USA); Group 2: Control:Uncoated circuits (Terumo,USA). Each group was further divided into three subgroups (N = 20) with respect to low (Euroscore 0-2), medium (3-5) and high (6+) risk patients. Results. Serum IL-2 levels were significantly lower in the study group at T4 and T5 (p < 0.01). C3a levels showed significant differences in the leukofiltrated group at T4 and T5 (p < 0.05). CPKMB levels demonstrated well-preserved myocardium in the leukofiltration group, post-operatively. AF incidence was 10% (2 patients) in the study and 35% (7 patients) in the control cohorts (p < 0.05). Phagocytic capacity on fibers in filtered patients was significantly lower. Conclusion: Leukofiltration and coating significantly reduce the incidence, ventricular rate, and duration of AF after CABG via modulation of systemic inflammatory response and platelet preservation in high risk groups. © 2007 Sage Publications.en_US
dc.language.isoengen_US
dc.relation.isversionof10.1177/0267659107084146en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleClinical effects of leukofiltration and surface modification on post-cardiopulmonary bypass atrial fibrillation in different risk cohortsen_US
dc.typearticleen_US
dc.contributor.departmentKırıkkale Üniversitesien_US
dc.identifier.volume22en_US
dc.identifier.issue4en_US
dc.identifier.startpage279en_US
dc.identifier.endpage288en_US
dc.relation.journalPerfusionen_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster